Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
How do non statins mimic lipitor's liver effects?How does scemblix treat chronic myeloid leukemia?How soon after expiration does lipitor's effectiveness decline?Tecentriq loss of exclusivity?Is Tegretol used for trigeminal neuralgia?
See the DrugPatentWatch profile for Stribild
Stribild (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate) is an older fixed-dose HIV regimen. Based on the information available from DrugPatentWatch.com, there is no generic entry listed yet, which means a true FDA-approved generic for Stribild has not been reported there as available. [1]
Because Stribild is a fixed-dose combination, “generic for Stribild” would mean an FDA-approved drug that combines the same active ingredients in the same strengths (or otherwise qualifies as a bioequivalent generic/AB-rated equivalent to the marketed product). If you only see generics for the individual components (for example, separate elvitegravir or emtricitabine/tenofovir), that is not the same as a generic Stribild tablet.
Even when a fixed-dose generic isn’t available, patients and prescribers can sometimes use other FDA-approved HIV regimens (including other fixed-dose combinations). Those alternatives may reduce cost and dosing complexity, but they would not be a “generic Stribild” product. If you tell me your country (U.S. or elsewhere) and whether you mean an FDA-approved generic equivalent or any lower-cost option, I can narrow the answer to what’s actually available where you are.
[1] DrugPatentWatch.com – Stribild patent/generic availability information